Guías de diagnóstico y tratamiento de diabetes gestacional. ALAD 2016
DOI:
https://doi.org/10.47196/diab.v50i3.45Palabras clave:
diabetes pregestacional, diabetes gestacional, embarazo, control, prueba de sobrecarga a la glucosa, monitoreo glucémicoResumen
En los últimos años el aumento de la prevalencia de obesidad y diabetes mellitus tipo 2 (DM2), la aparición a edades más tempranas de DM2, así como el desplazamiento del embarazo a edades mayores conllevan a un aumento de casos de diabetes (DM) en el embarazo.
En algunas pacientes la diabetes no se diagnostica y obviamente no se trata. Este hecho puede complicar un embarazo, especialmente en el período embriogénico. La aplicación de nuevos criterios de diagnóstico para la diabetes gestacional, la controversia en el uso y la seguridad de los antidiabéticos orales durante el embarazo, así como el uso de determinados análogos de insulina hacen indispensable que Latinoamérica, a través del Grupo de Trabajo de Diabetes y Embarazo de la Asociación Latinoamericana de Diabetes (ALAD), actualice sus recomendaciones. El desarrollo de las mismas se realizó en varias reuniones y trabajo conjunto del grupo. Se tuvo en cuenta el grado de nivel de evidencia, la experiencia de los referentes y la adaptación cultural según las regiones donde se implementarán las recomendaciones descriptas.
Citas
The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358:1991-2002.
World Health Organization/International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. WHO Document Production Services. Geneva, Switzerland, 2006.
Grupo de trabajo sobre GPC. Elaboración de Guías de Práctica Clínica en el Sistema Nacional de Salud. Manual Metodológico. Madrid: Plan Nacional para el SNS del MSC. Instituto Aragonés de Ciencias de la Salud I+CS; 2006.
Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Madsen R, Harris MI, Flegal KM, Eberhardt MS, Goldstein DE. Use of GHb (A1C) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000; 23:187-191.
Mazzei H, Pavetti M, Yapur G, Álvarez M, Bertona C, Cicchitti A, et al. Documento de las “Primeras Jornadas Conjuntas de Consenso del Laboratorio en Diabetes”. Sociedad Argentina de Diabetes, Capítulo Cuyo, Asociación Bioquímica de Mendoza y la Facultad de Farmacia y Bioquímica de la Universidad Juan Agustín Maza, Mendoza, 26 y 27 de junio de 2009.
Traverso R, Frechtel G, Traversa M, Garcia V, Sereday M, Peloche A, y col. Convergencias, divergencias, variabilidad, puntos de corte e indicación de la glucemia de ayuno, la hemoglobina glucosilada e insulinemia. Jornadas Rioplatenses, Colonia, República Oriental del Uruguay, 24 y 25 de abril de 2010.
Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation WHO/NCD/NCS/99.2. WHO, Geneva, Switzerland, 1999.
Lowe LP, Metzger BE. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care 2012; 35(3):574-80.
Rowan JA, Budden A, Sadler LC. Women with a nondiagnostic 75 g glucose tolerance test but elevated HbA1c in pregnancy. Aust N Z J Obstet Gynaecol 2014; 54(2):177-80.
Hashimoto K, Koga M. Indicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitus. World J Diabetes 2015; 6(8): 1045-1056.
Katon J. Antenatal haemoglobin A1c and risk of large-for-gestational-age infants in a multi-ethnic cohort of women with gestational diabetes. Paediatr Perinat Epidemiol 2012; 26(3):208-17.
Departamento de Enfermedades No Transmisibles. Departamento Ciclo Vital Guía. Diabetes y Embarazo. Ministerio de Salud, Gobierno de Chile, Santiago de Chile, Chile, 2015.
Consenso ALAD. Consenso Latinoamericano de Diabetes y Embarazo. ALAD. La Habana, Cuba, noviembre de 2007.
International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care 2010; 33 (3): 676-682.
Salzberg S. The Latin American Diabetes Asociation diagnosis of GDM. Revista de la Sociedad Argentina de Diabetes. Número Especial Scientific IADPSG Meeting 2016 2016; 50:10.
Visser G. Perinatal outcomes associated with the diagnosis of gestational diabetes made by The International Association of the Diabetes and Pregnancy Study Groups Criteria. Obstet Gynecol 2014; 124(3): 571-578.
World Health Organization (WHO). Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. WHO/NMH/MND/ 2013; 13.2.
Moses RG, Morris GJ, Petocz P, Gil FS, Garg D. The impact of the potential new diagnosis criteria on the prevalence of GDM in Australia. Med J Aust 2011; 194:338-340.
Alvariñas JH, Salzberg S. Diabetes gestacional: diagnóstico, tratamiento y criterios de derivación. En: Gagliardino JJ, Fabiano A, Alvariñas J, Sereday M, Sinay I. Ed. Diabetes tipo 2 no insulinodependiente: su diagnóstico, control y tratamiento. Rev Soc Arg Diabetes 1999; 177-186.
Salzberg S, Glatstein C, Faingold C, Cordini L, Alvariñas J. Recomendaciones para gestantes con diabetes. Obstetricia y Ginecología Latinoamericanas 2005; 1:3-19.
Donovan L, Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, et al. Screening tests for gestational diabetes: a systematic review for the U.S. preventive services task force. Ann Intern Med 2013; 159:115-122.
Asociación Latinoamericana de Diabetes. Consenso Latinoamericano de Diabetes y Embarazo. Revista ALAD 2008; 16 (2): 55-69.
Walker J. En: NICE guidance on diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE Clinical Guideline 63. Diabetic Medicine 2008; 25(9): 1025-1027.
Rivas AM. Diabetes mellitus gestacional: perfil materno. Valencia, Venezuela. 1986-2000. Revista de la ALAD 2011; 1 (3): 115-124.
Chu SY, Bachman DJ, Callaghan WM, Whitlock EP, Dietz PM, Berg CJ, et al. Association between obesity during pregnancy and increased use of health care. N Engl J Med 2008; 358:1444-1453.
Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, Dietz PM. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007; 30 (8): 2070-6.
Bloomgarden ZT. Gestational diabetes mellitus and obesity. Diabetes Care 2010; 33(5): 60-65.
Olmos PR, Rigotti A, Busso D, Berkowitz L, Santos J L, Borzone GR, et al. Maternal hypertriglyceridemia: a link between maternal overweight-obesity and macrosomia in gestational diabetes. Obesity (Silver Spring) 2014; 22(10):2156-63.
Nankervis A, McIntyre HD, Moses R, Ross GP, Callaway L, Porter C. ADIPS Consensus Guidelines for the Testing and Diagnosis of Hyperglycaemia in Pregnancy in Australia and New Zealand. Australasian Diabetes in Pregnancy Society 2014; 1-8.
MacNeill S, Dodds L, Hamilton DC, Armson BA, VandenHof M. Rates and risk factors for recurrence of gestational diabetes. Diabetes Care 2001; 24(4): 659-662.
Teh WT, Teede HJ, Paul E, Harrison CL, Wallace EM, Allan C. Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines. Aust N Z J Obstet Gynaecol 2011; 51(1): 26-30.
Mohammadbeigi A, Farhadifar F, Soufi zadeh N, Mohammadsalehi N, Rezaiee M, Aghaei M. Fetal macrosomia: risk factors, maternal, and perinatal outcome. Ann Med Health Sci Res 2013; 3(4):546-550.
Wendland EM, Torloni MR, Falavigna M, Trujillo J, Dode MA, Campos MA, et al. Gestational diabetes and pregnancy outcomes. A systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) Diagnostic Criteria 2012; 12:23.
Buchanan TA, Xiang AH. Gestational diabetes mellitus. Journal of Clinical Investigation 2015; 115(3):485-91.
Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 2007; 30 Suppl 2:S112-9.
Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006; 49(2):270-83.
Makgoba M, Savvidou MD, Steer PJ. An analysis of the interrelationship between maternal age, body mass index and racial origin in the development of gestational diabetes mellitus. BJOG 2012; 119(3):276-82.
Aulinas A, Biagetti B, Vinagre I, Capel I, Ubeda J, María MA, et al. Gestational diabetes mellitus and maternal ethnicity: high prevalence of fetal macrosomia in non-Caucasian women. Med Clin (Barc) 2013; 21;141(6):240-5.
Koivusalo SB. Gestational diabetes mellitus can be prevented by lifestyle intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL). A Randomized Controlled Trial. Diabetes Care 2016; 39:24-30.
Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clinical Chemistry 2002; 48(3), 436-472.
Sereday MS, Damiano MM, González CD, Bennett PH. Diagnostic criteria for gestational diabetes in relation to pregnancy outcome. J Diabetes Complications 2003; 17(3):115-9.
Lurie S, Mamet Y. Red blood cell survival and kinetics during pregnancy. Eur J Obstet Gynecol Reprod Biol 2000; 93(2):185-92.
Rebolledo OR, Actis Dato SM, Gagliardino JJ. Niveles de fructosamina en embarazadas con distinta edad de gestación y niños de primera y segunda infancia. Rev Soc Argent Diabetes 1997; 31(4):131-9.
Rizzo TA, Dooley SL, Metzger BE, Cho NH, Ogata ES, Silverman BL. Prenatal and perinatal influences on long-term psychomotor development in offspring of diabetic mothers. Am J Obstet Gynecol 1995; 173(6):1753-8.
Rasmussen KM. Weight gain during pregnancy: reexamining the guidelines. Institute of Medicine and National Research Council of The National Academies. The National Academies Press. Washington, D.C., U.S.A., 2009.
Calvo EB, López LB. Reference charts for weight gain and body mass index during pregnancy obtained from a healthy cohort. The Journal of Maternal Fetal and Neonatal Medicine 2009; 22(1): 36-42.
Rosso P, Mardones SF. Gráfica de incremento de peso para embarazadas. Rev Hosp Mat Inf Ramón Sardá 1996; XV (3): 123-126.
Standards of Medical Care in Diabetes 2016: Summary of Revisions. Diabetes Care 2016; 39 (Suppl. 1):S4-S5.
Mathiesen E, Secher A, Parellada C, Ringholm L, Damm P, Ásbjörnsdóttir B. Higher gestational weight gain is associated with increasing offspring birth weight independent of maternal glycemic control in women with type 1. Diabetes Care 2014; 37(10): 2677-2684.
Rivas AM. Uso de los análogos de la insulina durante el embarazo. Rev Venez Endocrinol Metab 2012; 10 (3):135-141.
Woolderink JM, Van loon AJ, Storms F, de Heide L, Hoogenberg K. Use of insulin glargine during pregnancy in seven type 1 diabetic women. Diab. Care 2005; 28: 2594-2595.
Devlin JT, Hothersall L, Wilkis JL. Use of insulin glargine during pregnancy in a type 1 diabetic woman. Diab Care 2002; 25: 1095-1096.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health (CADTH) Canadian Optimal Medication Prescribing and Utilization Service (COMPUS). Optimal therapy recommendations for the prescribing and use of insulin analogues; Ottawa, Canada, 2010.
Cheng AY, Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Clinical Practice Guidelines for the Prevention and Management of diabetes in Canada. Can J Diabetes 2013; (37): S1-S3.
Mathiesen ER. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007 Apr; 30(4):771-6.
Green MF, Bentley-Lewis R. Medical management of type 1 and type 2 diabetes mellitus in pregnant women. En: UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, USA, 2014, Topic 4802 Version 20.0.
Farrar D, Tuffnel DJ, West J. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 2007; 18(3):CD005542.
Ya-chang Z. The use of glyburide in the management of gestational diabetes mellitus: a meta-analysisAdvances in Medical Sciences 2014; 59 (1): 95-101.
Glueck CJ, Pranikoff J , Aregawi D, Wang P. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertility and sterility. 2008; 89(3): 625-634.
Füchtenbusch M, Ferber K, Standl E, Ziegler AG. Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes 1997; 46(9):1459-67.
Naylor R, Philipson LH. Who should have genetic testing for maturity-onset diabetes of the young? Clin Endocrinol 2011; 75 (4):422-426.
Rivas AM, Guerra CA, Gonzáles JC, Guevara MC, Davila SG. Mujeres con diabetes mellitus gestacional previa incorporadas a programa de seguimiento postparto. Revista ALAD 2010; Vol 18 (1): 16-24.
NICE Guidelines (NG3). Diabetes in pregnancy: management from preconception to the postnatal period. National Institute for Health and Care Excellence. London, UK, 2015.
Medical Eligibility Criteria for Contraceptive Use: A WHO Family Planning Cornerstone. World Health Organization. 4th Ed., Geneva, Swithzerland, 2010.
Dornhorst A. Revista de la Sociedad Argentina de Diabetes 2016; Vol. 50, Nº Especial Scientific IADPSG Meeting 2016, 50:11.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
